← All organizations

Choline Alfoscerate Re-evaluation Consortium

Academic/Hospital

Also known as: Choline Alfoscerate Re-evaluation Consortium (57 pharmaceutical companies)

Highest phase reached

Phase 4

First clinical trial

Sep 30, 2021

Last known activity

Sep 30, 2021

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 2 trials)

Phase 4 (1 own, 0 via acquisition)

Recent trials (2)

Details

Last known activity
Sep 30, 2021